CPC A61K 31/337 (2013.01) [A61K 9/0053 (2013.01); A61K 9/1075 (2013.01); A61K 9/4858 (2013.01); A61K 31/4725 (2013.01); A61K 45/06 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/26 (2013.01); A61K 47/44 (2013.01)] | 15 Claims |
1. A method of treating cancer, comprising orally administering a pharmaceutical composition to an individual in need of treatment for cancer, wherein the pharmaceutical composition comprises a taxane solution consisting of the taxane and a surfactant mixture consisting of a first surfactant that is polysorbate 80 and a second surfactant that is propane-1,2,3-triol-oxirane, wherein the ratio of the first surfactant to the second surfactant in the pharmaceutical composition is from 65:35 to 80:20 by weight, wherein the first surfactant and the second surfactant comprise at least 90% of the pharmaceutical composition by weight, and wherein the pharmaceutical composition is effective to form a micellar suspension.
|